Clinical Trials Directory

Trials / Conditions / Juvenile Psoriatic Arthritis

Juvenile Psoriatic Arthritis

10 registered clinical trials studyying Juvenile Psoriatic Arthritis — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingStudy to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secuk
NCT06751238
Novartis PharmaceuticalsPhase 1
RecruitingA Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Partici
NCT06869551
Bristol-Myers SquibbPhase 3
RecruitingAn Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants
NCT06668181
UCB Biopharma SRLPhase 3
RecruitingA Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Child
NCT06100744
AbbViePhase 3
RecruitingA Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arth
NCT05767047
AmgenPhase 3
CompletedTransition to Adulthood Through Coaching and Empowerment in Rheumatology
NCT05545839
McMaster UniversityN/A
CompletedA Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or Psoriasis
NCT05252533
Janssen Research & Development, LLCPhase 1
Active Not RecruitingA Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-rela
NCT04527380
Eli Lilly and CompanyPhase 3
CompletedAn Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthes
NCT03769168
Novartis PharmaceuticalsPhase 3
CompletedSecukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA)
NCT03031782
Novartis PharmaceuticalsPhase 3